Whether you're an investor, entrepreneur, researcher or simply interested in the bio-revolution, this report provides invaluable insights into where money is flowing, which companies are attracting funding, year-over-year investment figures, and more. Understand the key players, buzzing sectors, regional hotspots and financial forces shaping the future of synthetic biology. Don't miss out on this opportunity to access over a decade's worth of investment data for one of today's most transformative technology frontiers.
Craving even more insights into the booming synthetic biology industry? Don’t miss out on this year's SynBioBeta Global Synthetic Biology Conference happening May 5-8 in San Jose. This premier event is putting the spotlight on investing and financial opportunities in the synthetic bio space.
Click here to purchase tickets.
SynBioBeta’s Annual Synthetic Biology Investment Report - Insights Into What Could Be In Store for ‘25 - Recorded Webinar
“After a significant surge in funding that began in 2020 and peaked in 2021, synthetic biology investment experienced a cooling period in 2022 and 2023. But in 2024, the sector rebounded strongly—venture investment reached $12.2 billion year-to-date, up from $10.7 billion in 2023, driven by a standout Q4. This recovery signals renewed investor confidence, fueled by both capital flowing into existing companies and a new wave of startups entering the field. While the market continues to mature and investment decisions grow more discerning, current funding levels remain well above pre-pandemic norms, underscoring the field’s long-term momentum and resilience.
Catch up now on insights from SynBioBeta's CEO, John Cumbers, and Futurity Systems' CTO, Mark Bünger. Discover details from the SynBioBeta’s 2025 Annual Synthetic Biology Investment Report. Watch the recording here!
.svg)
